Here at Last: Treatment Options for VEXASNovember 15, 2023View Article New Biomarkers and Therapeutics Show Potential in Still's DiseaseNovember 14, 2023View Article Anakinra Effective in Systemic JIA, Irrespective of HLA-DRB1 and IL1RN VariantsNovember 06, 2023View Article Sleep Apnea Smart Watches (10.13.2023)October 13, 2023View Article FDA Approves Canakinumab for Gout FlaresAugust 30, 2023View Article Mono- and Oligo- are Different (8.18.2023)August 18, 2023View Article EULAR/ACR Guidance on Haemophagocytic Lymphohistiocytosis/Macrophage Activation SyndromeJuly 26, 2023View Article ICYMI: LAVLI – A New Autoinflammatory DisorderJuly 06, 2023View Article EULAR 2023 Notes from Milan (6.09.2023)June 09, 2023View Article AOSD: Young vs. Elderly OnsetJune 01, 2023View Article LAVLI – A New Autoinflammatory DisorderMarch 28, 2023View Article VEXAS may be more common than expectedJanuary 25, 2023View Article Holes in TH17 cells release IL-1α on NLRP3 activationJanuary 10, 2023View Article Best of 2022: Five Mistakes When Diagnosing Still’s DiseaseDecember 26, 2022View Article Best of 2022: Myths & Misconceptions with Febrile DisordersDecember 23, 2022View Article ACR 2022 Appraisal, Praise & Critique (11.18.2022)November 18, 2022View Article Load more × Go to Top SOLVING STILL’S DISEASE Sign up TO THE NEW MONTHLY EMAIL Still’s Disease & Autoinflammatory Reader Type Rheumatologist Patient or Concerned Individual Media/Press Other Healthcare Professional Other Physician Pharmaceutical Industry or Biotech Individual Pharmacist Physician Assistant, Nurse Practitioner, Rheumatology Nurse Primary Physician Trainee (Fellow, Resident, Student) Monthly Topic Digests (Choose one or many) Autoinflammatory & Still's Disease (via StillsNow) Email address: Leave this field empty if you're human:
New Biomarkers and Therapeutics Show Potential in Still's DiseaseNovember 14, 2023View Article Anakinra Effective in Systemic JIA, Irrespective of HLA-DRB1 and IL1RN VariantsNovember 06, 2023View Article Sleep Apnea Smart Watches (10.13.2023)October 13, 2023View Article FDA Approves Canakinumab for Gout FlaresAugust 30, 2023View Article Mono- and Oligo- are Different (8.18.2023)August 18, 2023View Article EULAR/ACR Guidance on Haemophagocytic Lymphohistiocytosis/Macrophage Activation SyndromeJuly 26, 2023View Article ICYMI: LAVLI – A New Autoinflammatory DisorderJuly 06, 2023View Article EULAR 2023 Notes from Milan (6.09.2023)June 09, 2023View Article AOSD: Young vs. Elderly OnsetJune 01, 2023View Article LAVLI – A New Autoinflammatory DisorderMarch 28, 2023View Article VEXAS may be more common than expectedJanuary 25, 2023View Article Holes in TH17 cells release IL-1α on NLRP3 activationJanuary 10, 2023View Article Best of 2022: Five Mistakes When Diagnosing Still’s DiseaseDecember 26, 2022View Article Best of 2022: Myths & Misconceptions with Febrile DisordersDecember 23, 2022View Article ACR 2022 Appraisal, Praise & Critique (11.18.2022)November 18, 2022View Article Load more × Go to Top SOLVING STILL’S DISEASE Sign up TO THE NEW MONTHLY EMAIL Still’s Disease & Autoinflammatory Reader Type Rheumatologist Patient or Concerned Individual Media/Press Other Healthcare Professional Other Physician Pharmaceutical Industry or Biotech Individual Pharmacist Physician Assistant, Nurse Practitioner, Rheumatology Nurse Primary Physician Trainee (Fellow, Resident, Student) Monthly Topic Digests (Choose one or many) Autoinflammatory & Still's Disease (via StillsNow) Email address: Leave this field empty if you're human:
Anakinra Effective in Systemic JIA, Irrespective of HLA-DRB1 and IL1RN VariantsNovember 06, 2023View Article Sleep Apnea Smart Watches (10.13.2023)October 13, 2023View Article FDA Approves Canakinumab for Gout FlaresAugust 30, 2023View Article Mono- and Oligo- are Different (8.18.2023)August 18, 2023View Article EULAR/ACR Guidance on Haemophagocytic Lymphohistiocytosis/Macrophage Activation SyndromeJuly 26, 2023View Article ICYMI: LAVLI – A New Autoinflammatory DisorderJuly 06, 2023View Article EULAR 2023 Notes from Milan (6.09.2023)June 09, 2023View Article AOSD: Young vs. Elderly OnsetJune 01, 2023View Article LAVLI – A New Autoinflammatory DisorderMarch 28, 2023View Article VEXAS may be more common than expectedJanuary 25, 2023View Article Holes in TH17 cells release IL-1α on NLRP3 activationJanuary 10, 2023View Article Best of 2022: Five Mistakes When Diagnosing Still’s DiseaseDecember 26, 2022View Article Best of 2022: Myths & Misconceptions with Febrile DisordersDecember 23, 2022View Article ACR 2022 Appraisal, Praise & Critique (11.18.2022)November 18, 2022View Article Load more × Go to Top SOLVING STILL’S DISEASE Sign up TO THE NEW MONTHLY EMAIL Still’s Disease & Autoinflammatory Reader Type Rheumatologist Patient or Concerned Individual Media/Press Other Healthcare Professional Other Physician Pharmaceutical Industry or Biotech Individual Pharmacist Physician Assistant, Nurse Practitioner, Rheumatology Nurse Primary Physician Trainee (Fellow, Resident, Student) Monthly Topic Digests (Choose one or many) Autoinflammatory & Still's Disease (via StillsNow) Email address: Leave this field empty if you're human:
Sleep Apnea Smart Watches (10.13.2023)October 13, 2023View Article FDA Approves Canakinumab for Gout FlaresAugust 30, 2023View Article Mono- and Oligo- are Different (8.18.2023)August 18, 2023View Article EULAR/ACR Guidance on Haemophagocytic Lymphohistiocytosis/Macrophage Activation SyndromeJuly 26, 2023View Article ICYMI: LAVLI – A New Autoinflammatory DisorderJuly 06, 2023View Article EULAR 2023 Notes from Milan (6.09.2023)June 09, 2023View Article AOSD: Young vs. Elderly OnsetJune 01, 2023View Article LAVLI – A New Autoinflammatory DisorderMarch 28, 2023View Article VEXAS may be more common than expectedJanuary 25, 2023View Article Holes in TH17 cells release IL-1α on NLRP3 activationJanuary 10, 2023View Article Best of 2022: Five Mistakes When Diagnosing Still’s DiseaseDecember 26, 2022View Article Best of 2022: Myths & Misconceptions with Febrile DisordersDecember 23, 2022View Article ACR 2022 Appraisal, Praise & Critique (11.18.2022)November 18, 2022View Article Load more × Go to Top SOLVING STILL’S DISEASE Sign up TO THE NEW MONTHLY EMAIL Still’s Disease & Autoinflammatory Reader Type Rheumatologist Patient or Concerned Individual Media/Press Other Healthcare Professional Other Physician Pharmaceutical Industry or Biotech Individual Pharmacist Physician Assistant, Nurse Practitioner, Rheumatology Nurse Primary Physician Trainee (Fellow, Resident, Student) Monthly Topic Digests (Choose one or many) Autoinflammatory & Still's Disease (via StillsNow) Email address: Leave this field empty if you're human:
FDA Approves Canakinumab for Gout FlaresAugust 30, 2023View Article Mono- and Oligo- are Different (8.18.2023)August 18, 2023View Article EULAR/ACR Guidance on Haemophagocytic Lymphohistiocytosis/Macrophage Activation SyndromeJuly 26, 2023View Article ICYMI: LAVLI – A New Autoinflammatory DisorderJuly 06, 2023View Article EULAR 2023 Notes from Milan (6.09.2023)June 09, 2023View Article AOSD: Young vs. Elderly OnsetJune 01, 2023View Article LAVLI – A New Autoinflammatory DisorderMarch 28, 2023View Article VEXAS may be more common than expectedJanuary 25, 2023View Article Holes in TH17 cells release IL-1α on NLRP3 activationJanuary 10, 2023View Article Best of 2022: Five Mistakes When Diagnosing Still’s DiseaseDecember 26, 2022View Article Best of 2022: Myths & Misconceptions with Febrile DisordersDecember 23, 2022View Article ACR 2022 Appraisal, Praise & Critique (11.18.2022)November 18, 2022View Article Load more × Go to Top
Mono- and Oligo- are Different (8.18.2023)August 18, 2023View Article EULAR/ACR Guidance on Haemophagocytic Lymphohistiocytosis/Macrophage Activation SyndromeJuly 26, 2023View Article ICYMI: LAVLI – A New Autoinflammatory DisorderJuly 06, 2023View Article EULAR 2023 Notes from Milan (6.09.2023)June 09, 2023View Article AOSD: Young vs. Elderly OnsetJune 01, 2023View Article LAVLI – A New Autoinflammatory DisorderMarch 28, 2023View Article VEXAS may be more common than expectedJanuary 25, 2023View Article Holes in TH17 cells release IL-1α on NLRP3 activationJanuary 10, 2023View Article Best of 2022: Five Mistakes When Diagnosing Still’s DiseaseDecember 26, 2022View Article Best of 2022: Myths & Misconceptions with Febrile DisordersDecember 23, 2022View Article ACR 2022 Appraisal, Praise & Critique (11.18.2022)November 18, 2022View Article Load more ×
EULAR/ACR Guidance on Haemophagocytic Lymphohistiocytosis/Macrophage Activation SyndromeJuly 26, 2023View Article ICYMI: LAVLI – A New Autoinflammatory DisorderJuly 06, 2023View Article EULAR 2023 Notes from Milan (6.09.2023)June 09, 2023View Article AOSD: Young vs. Elderly OnsetJune 01, 2023View Article LAVLI – A New Autoinflammatory DisorderMarch 28, 2023View Article VEXAS may be more common than expectedJanuary 25, 2023View Article Holes in TH17 cells release IL-1α on NLRP3 activationJanuary 10, 2023View Article Best of 2022: Five Mistakes When Diagnosing Still’s DiseaseDecember 26, 2022View Article Best of 2022: Myths & Misconceptions with Febrile DisordersDecember 23, 2022View Article ACR 2022 Appraisal, Praise & Critique (11.18.2022)November 18, 2022View Article Load more ×
ICYMI: LAVLI – A New Autoinflammatory DisorderJuly 06, 2023View Article EULAR 2023 Notes from Milan (6.09.2023)June 09, 2023View Article AOSD: Young vs. Elderly OnsetJune 01, 2023View Article LAVLI – A New Autoinflammatory DisorderMarch 28, 2023View Article VEXAS may be more common than expectedJanuary 25, 2023View Article Holes in TH17 cells release IL-1α on NLRP3 activationJanuary 10, 2023View Article Best of 2022: Five Mistakes When Diagnosing Still’s DiseaseDecember 26, 2022View Article Best of 2022: Myths & Misconceptions with Febrile DisordersDecember 23, 2022View Article ACR 2022 Appraisal, Praise & Critique (11.18.2022)November 18, 2022View Article Load more ×
EULAR 2023 Notes from Milan (6.09.2023)June 09, 2023View Article AOSD: Young vs. Elderly OnsetJune 01, 2023View Article LAVLI – A New Autoinflammatory DisorderMarch 28, 2023View Article VEXAS may be more common than expectedJanuary 25, 2023View Article Holes in TH17 cells release IL-1α on NLRP3 activationJanuary 10, 2023View Article Best of 2022: Five Mistakes When Diagnosing Still’s DiseaseDecember 26, 2022View Article Best of 2022: Myths & Misconceptions with Febrile DisordersDecember 23, 2022View Article ACR 2022 Appraisal, Praise & Critique (11.18.2022)November 18, 2022View Article Load more ×
AOSD: Young vs. Elderly OnsetJune 01, 2023View Article LAVLI – A New Autoinflammatory DisorderMarch 28, 2023View Article VEXAS may be more common than expectedJanuary 25, 2023View Article Holes in TH17 cells release IL-1α on NLRP3 activationJanuary 10, 2023View Article Best of 2022: Five Mistakes When Diagnosing Still’s DiseaseDecember 26, 2022View Article Best of 2022: Myths & Misconceptions with Febrile DisordersDecember 23, 2022View Article ACR 2022 Appraisal, Praise & Critique (11.18.2022)November 18, 2022View Article Load more ×
LAVLI – A New Autoinflammatory DisorderMarch 28, 2023View Article VEXAS may be more common than expectedJanuary 25, 2023View Article Holes in TH17 cells release IL-1α on NLRP3 activationJanuary 10, 2023View Article Best of 2022: Five Mistakes When Diagnosing Still’s DiseaseDecember 26, 2022View Article Best of 2022: Myths & Misconceptions with Febrile DisordersDecember 23, 2022View Article ACR 2022 Appraisal, Praise & Critique (11.18.2022)November 18, 2022View Article Load more ×
VEXAS may be more common than expectedJanuary 25, 2023View Article Holes in TH17 cells release IL-1α on NLRP3 activationJanuary 10, 2023View Article Best of 2022: Five Mistakes When Diagnosing Still’s DiseaseDecember 26, 2022View Article Best of 2022: Myths & Misconceptions with Febrile DisordersDecember 23, 2022View Article ACR 2022 Appraisal, Praise & Critique (11.18.2022)November 18, 2022View Article Load more ×
Holes in TH17 cells release IL-1α on NLRP3 activationJanuary 10, 2023View Article Best of 2022: Five Mistakes When Diagnosing Still’s DiseaseDecember 26, 2022View Article Best of 2022: Myths & Misconceptions with Febrile DisordersDecember 23, 2022View Article ACR 2022 Appraisal, Praise & Critique (11.18.2022)November 18, 2022View Article Load more ×
Best of 2022: Five Mistakes When Diagnosing Still’s DiseaseDecember 26, 2022View Article Best of 2022: Myths & Misconceptions with Febrile DisordersDecember 23, 2022View Article ACR 2022 Appraisal, Praise & Critique (11.18.2022)November 18, 2022View Article Load more ×
Best of 2022: Myths & Misconceptions with Febrile DisordersDecember 23, 2022View Article ACR 2022 Appraisal, Praise & Critique (11.18.2022)November 18, 2022View Article Load more ×
Articles
